Essity Reviews Consumer Tissue Business
Analysis based on 6 articles · First reported May 06, 2026 · Last updated May 06, 2026
Essity, a global hygiene and health company, has initiated a strategic review of its Consumer Tissue business area's global operations. This review aims to evaluate strategic alternatives to optimize Essity's product portfolio and maximize value creation, with potential outcomes including a separation of the business. The Consumer Tissue business, which includes brands like Lotus, Tempo, and Zewa, accounted for 31% of Essity's net sales in 2025. Essity is the market leader in Europe and the second largest player in Latin America in this segment. The company also announced it would host its Capital Markets Day on May 7, 2026.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard